Patient Self-Monitoring and Red Flag Symptoms Patients should be educated to recognize and report concerning symptoms promptly: Chest pain or pressure, especially with exertion Severe or persistent palpitations Unexplained shortness of breath Syncope (fainting) or near-syncope New or worsening leg swelling Persistent dizziness or lightheadedness Home blood pressure and heart rate monitoring may be beneficial for patients with hypertension or those experiencing symptoms
The expanded regulatory approvals for chronic weight management and cardiovascular risk reduction are a few of the key factors driving market growth
While our clinical studies have not been designed to assess the ability of semaglutide on tobacco use disorder or other addiction-related illnesses, data from nonclinical, clinical, and post-marketing sources have not shown any evidence indicating a causal relationship between semaglutide and TUD or addiction-related illnesses, the company said in a Monday statement to The Post.
Of 41 792 patients who discontinued and had a discontinuation weight measurement available, 1-year reinitiation was lower for those without type 2 diabetes (36.3% [95% CI, 35.6%-37.0%]) compared with those with type 2 diabetes (47.3% [95% CI, 46.6%-48.0%])
A subsequent post hoc analysis explored the drugs effects on individual non-motor symptoms, revealing improvements in mood/depression and emotional well-being that were not maintained after drug withdrawal [82]
This ensures the highest standard of scientific accuracy